Compare ALLO & CZFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALLO | CZFS |
|---|---|---|
| Founded | 2017 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 268.6M |
| IPO Year | 2018 | N/A |
| Metric | ALLO | CZFS |
|---|---|---|
| Price | $1.80 | $63.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $8.27 | N/A |
| AVG Volume (30 Days) | ★ 6.3M | 13.6K |
| Earning Date | 03-12-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 3.13% |
| EPS Growth | N/A | ★ 31.56 |
| EPS | N/A | ★ 7.62 |
| Revenue | N/A | ★ $109,970,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | ★ N/A | $8.39 |
| Revenue Growth | N/A | ★ 10.78 |
| 52 Week Low | $0.86 | $49.96 |
| 52 Week High | $3.78 | $69.30 |
| Indicator | ALLO | CZFS |
|---|---|---|
| Relative Strength Index (RSI) | 58.49 | 52.15 |
| Support Level | $1.56 | $61.85 |
| Resistance Level | $1.84 | $65.97 |
| Average True Range (ATR) | 0.16 | 2.89 |
| MACD | -0.01 | -0.40 |
| Stochastic Oscillator | 67.96 | 61.08 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.